Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine

NCT01831050 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

1420

Enrollment

OTHER

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Bivalent Oral Polio Vaccine (bOPV)
BIOLOGICAL: Trivalent Oral Polio Vaccine (tOPV)
BIOLOGICAL: Monovalent Oral Polio Vaccine Type 2 (mOPV2)
BIOLOGICAL: Sanofi-Pasteur IPV (Sanofi IPV)
BIOLOGICAL: Glaxo SmithKline IPV (GSK IPV)
BIOLOGICAL: Serum Institute of India IPV (SII IPV)

Sponsor

Fidec Corporation

Collaborators

[object Object]
[object Object]